fbpx An update on Mmr | Page 119 | Science in the net

An update on Mmr

Primary tabs

Read time: 1 min

Measles, mumps and rubella outbreaks still represent an healthcare issue, even though major advancements have been done towards their eradication. A poor inclination towards Mmr (measles-mumps-rubella) vaccination may constitute a major cause of increased risk to contract one of these diseases amongst specific population groups like migrants, alternative medicine users, some religious groups, healthcare professionals.
Information on Mmr vaccines coverage amongst these and others “hard-to-reach” groups was included in a document made and published Ecdc in range of the European project Venice II (Vaccine European New Integrated Collaboration Effort II). Main aim of the document was to provide a complete review of measles, mumps and rubella focuses which have been reported in the last twenty years in Europe.

Autori: 
Sezioni: 
Indice: 
Vaccination

prossimo articolo

Adeus basic research, welcome Commissioner Moedas

The Jean-Claude Juncker's new Commission is taking shape. The first moves showed that the Barroso structure will be changed completely. This new course has invested the scientific policymaking, starting from the appointment of the new Commissioner on Science and Innovation. Rumors said that Juncker initially preferred a Portuguese woman, Maria Luis Albuquerque, Minister of Finance in Lisbon. But